Birzeit Pharmaceuticals Company (PEX:BPC)

PEX:BPC Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	105	122	120	120	121	78
Market Cap Growth	1.82%	2.24%	-0.56%	-0.94%	56.41%	6.71%
Enterprise Value	102	120	111	109	111	72
Last Close Price	2.71	3.11	3.00	2.98	2.94	1.85

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	13.79	14.44	32.54	27.70	21.51	9.07
PS Ratio	3.17	3.60	4.15	3.93	3.64	2.41
PB Ratio	1.26	1.50	1.61	1.61	1.65	1.18
P/TBV Ratio	1.26	1.51	1.62	1.62	1.67	1.19
P/FCF Ratio	89.46	43905.27	31.03	19.18	105.72	40.29
P/OCF Ratio	51.22	73.87	24.23	13.93	32.84	30.02

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	3.09	3.52	3.85	3.55	3.34	2.23
EV/EBITDA Ratio	12.53	13.93	17.27	17.63	13.99	8.45
EV/EBIT Ratio	14.26	15.76	20.47	21.30	16.42	9.82
EV/FCF Ratio	87.20	43002.35	28.78	17.32	97.07	37.24

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.01	-	-	-	0.01	0.02
Debt / EBITDA Ratio	0.06	-	-	-	0.11	0.17
Debt / FCF Ratio	0.40	-	-	-	0.75	0.75
Net Debt / Equity Ratio	-0.04	-0.04	-0.15	-0.16	-0.15	-0.13
Net Debt / EBITDA Ratio	-0.38	-0.39	-1.71	-1.98	-1.37	-0.98
Net Debt / FCF Ratio	-2.66	-1216.30	-2.85	-1.95	-9.53	-4.33
Asset Turnover	0.33	0.36	0.32	0.35	0.40	0.43
Inventory Turnover	2.10	2.48	2.20	2.22	2.53	2.36
Quick Ratio	3.47	4.43	4.48	6.58	7.15	6.51
Current Ratio	4.27	5.44	5.45	8.22	9.01	8.31
Return on Equity (ROE)	9.43%	10.82%	4.94%	5.90%	8.08%	14.10%
Return on Assets (ROA)	4.51%	4.98%	3.76%	3.62%	5.08%	6.11%
Return on Invested Capital (ROIC)	7.90%	9.76%	7.39%	7.17%	9.94%	12.40%
Return on Capital Employed (ROCE)	7.80%	8.40%	6.60%	6.10%	8.30%	9.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	7.25%	6.93%	3.07%	3.61%	4.65%	11.03%
FCF Yield	1.12%	0.00%	3.22%	5.21%	0.95%	2.48%
Dividend Yield	1.31%	1.12%	1.15%	1.14%	2.06%	1.77%
Payout Ratio	18.08%	16.22%	37.40%	63.39%	24.39%	23.60%
Buyback Yield / Dilution	-	-	-	-2.30%	2.38%	-
Total Shareholder Return	1.31%	1.12%	1.15%	-1.15%	4.44%	1.77%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error